This content is machine translated 19th Zurich Cardiovascular Day Brain stroke – a clinical picture from two different perspectives Two experts from different fields spoke on the topic of “cerebral stroke” at the 19th Zurich Cardiovascular Day. From a neurological perspective, cerebral microbleeds have been identified as a risk…
View Post 2 min This content is machine translated Personalized vaccination Each patient gets his own medicine Advances in so-called cancer vaccines were discussed at the ESMO Symposium on Immuno-oncology in Geneva. In the most elaborate study to date on this topic, researchers are currently investigating the…
View Post 2 min This content is machine translated Research result at the University of Bern An alternative to antibiotics? An international team of researchers led by Bern has developed a new substance to treat severe bacterial infections – without the use of antibiotics. This could also prevent antibiotic resistance…
View Post 2 min This content is machine translated Cancer risk with contraception with IUD Neither baby nor cancer Recently, evidence has accumulated in the literature that intrauterine devices may reduce the risk of developing endometrial cancer. What is the current study situation on this? This question was explored…
View Post 7 min This content is machine translated European Diabetes Congress in Vienna High expectations for new therapeutic options At the EASD congress in Vienna, gliptins, gliflozines and further improved insulins were seen as the great hope in diabetology. But medical technology also presented itself in a good position;…
View Post 7 min This content is machine translated Heart failure Guidelines, telemonitoring, and lessons from negative studies. At the three-country meeting in Bern on the topic of heart failure, experts spoke about the implementation of the guidelines in practice and went into more detail about the possibilities…
View Post 4 min This content is machine translated Meningiomas Therapeutic options for recurrent or metastatic tumors A “Special Session” at the ESMO Congress focused on meningiomas. Although these brain tumors are primarily treated surgically, higher-grade meningiomas that can grow invasively may require radio or systems therapy.
View Post 4 min This content is machine translated Metastatic colorectal cancer Which first-line therapy for patients with wild-type RAS? At this year’s ESMO Congress in Madrid, treatment options for metastatic colorectal cancer were also discussed. Is there an optimal strategy for patients with a wild-type RAS mutation, and would…
View Post 2 min This content is machine translated RAINBOW Study New standard in the second line? Drugs that are well established in first-line advanced gastric cancer continue to achieve relatively poor survival prognoses in second-line settings. A new study (RAINBOW) now demonstrates the efficacy of ramucirumab…
View Post 2 min This content is machine translated Glioblastoma Moving forward with combined forces Considering that glioblastomas are among the most common and malignant brain tumors and have a very poor prognosis, optimizations of the current therapy are urgently needed. Two publications are attracting…
View Post 2 min This content is machine translated Breast Cancer Proliferation stimulated by soy? There are several epidemiological studies linking soy to a reduced risk of breast cancer or recurrence. At the same time, the phytoestrogens contained in soy, genistein and daidzein, achieve a…
